Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arotinolol Hydrochloride in Hypertensive Haemodialysis Patients
NCT01351636Phase 4Completed
- Sponsor
- Sumitomo Pharma
- Start
- Apr 2011
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of arotinolol in hypertension (HTN), sponsored by Sumitomo Pharma. Started Apr 2011; status: completed.
02
Drugs
arotinolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01351636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01351636.